Is there a requirement for the clinical evaluation to assess comparable or similar devices even if you do not plan to utilize equivalency as a route to conformity? | BradyKnows

Subscribe

if you plan to use your own clinical study data, you do not need to demonstrate equivalency.

Suggested Reading

GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
What factors may affect biocompatibility risk when using biological test data from similar devices for…
How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
When combining subchronic and implantation tests in one project, what factors need to be considered, and how can…
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
Do all medical devices require chemical characterization?
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation…
GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests…

Previous: Chinese CER did not used to need state of art, you mean now they do? like the EU CER?

Next: What is exactly meant by intended clinical superiority for state of the art- China CER?